Science · 2 sources covering this

DR Congo Ebola vaccine trial to begin within weeks: WHO

Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will go through a full-scale human trial in the DRC to see if it offers any cross-protection against Bundibugyo

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

2 L · 0 C · 0 R

How 2 sources are covering this

The HinduLean L·1h ago
DR Congo Ebola vaccine trial to begin within weeks: WHO
Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will go through a full-scale human trial in the DRC to see if it offers any cross-protection against Bundibugyo
Read at The Hindu →
The HinduLean L·1h ago

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/a2f9c5e411e59a15c96dd90fffde15978911ecf1"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="DR Congo Ebola vaccine trial to begin within weeks: WHO"></iframe>

DR Congo Ebola vaccine trial to begin within weeks: WHO

How 2 sources are covering this

DR Congo Ebola vaccine trial to begin within weeks: WHO

More from Science

Mining project threatens future of rare Jeypore ground gecko

Limiting warming to 1.8 degree C could prevent loss of 1.89 billion years of healthy life: Analysis

DR Congo Ebola vaccine trial to begin within weeks: WHO

Spotlighting maternal health: why care after delivery is crucial

The back end of 55

Reader

Trust & legal

Across the network